heart iconheart icon
Share
Innovation
Working to Redefine Healthcare: FORTUNE Magazine Names Johnson & Johnson #1 in Pharmaceuticals

We are honored that for the second consecutive year FORTUNE Magazine ranked Johnson & Johnson and its Janssen Pharmaceutical Companies #1 in the Pharmaceuticals category on its annual World’s Most Admired Companies list. It is a reflection of the hard work, passion and dedication of our Janssen team, and a testament to our commitment to improve people’s lives around the world.

At Janssen, what matters most is a healthy outcome for every patient and this cannot be achieved by simply making incremental improvements to healthcare. We must continue to be bold, collaborative and innovative. Here are some examples of progress we’ve made over the past year:

  • Our efforts to combat Ebola, in partnership with Bavarian Nordic and consortia of leading global research institutions and NGOs reflect our commitment to global public health;
  • New recently-launched research platforms — the Janssen Prevention Center, the Disease Interception Accelerator, and the Janssen Human Microbiome Institute — focus in three areas of transformational medical innovation that are expected to change the global healthcare landscape.

In addition to earning the top ranking in the pharmaceutical industry, Johnson & Johnson also ranked highest in 6 out of 9 key reputation attributes: people management, use of corporate assets, social responsibility, quality of management, financial soundness, and long term investment value. Further, we maintained or improved our pharmaceutical industry ranking on the remaining 3 key reputation attributes: quality of products/services, global competitiveness, and innovation.

Each day, the people of Janssen and Johnson & Johnson work together to redefine healthcare. We are proud to be recognized by FORTUNE and will continue forward with a sense of urgency and passion for what matters most — the people who entrust us with their health.